Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Select your origin of interest
SPRY1 maybe a negative feedback regulator in normal human epidermal keratinocytes.
FREM2 is thus proposed as a novel GB biomarker and a putative biomarker of glioblastoma stem cells. Both FREM2 and SPRY1 are expressed on the surface of the GB cells, while SPRY1 alone was found overexpressed in the cytosol of non-malignant astrocytes.
Inhibition of miR (show MLXIP Proteins)-29b could attenuate atherosclerosis by inhibiting the SPRY1/MAPK (show MAPK1 Proteins) signaling pathway and inflammation in aorta.
During adipogenesis and osteogenesis, TNF-alpha (show TNF Proteins) significantly increased Spry1 levels and overexpression of miR (show MLXIP Proteins)-21 dramatically decreased Spry1 levels in the presence of TNF-alpha (show TNF Proteins), indicated important roles of miR (show MLXIP Proteins)-21 in modulating link between TNF-alpha (show TNF Proteins) and Spry1. Our findings introduce a molecular mechanism in which TNF-alpha (show TNF Proteins) suppresses adipogenic and osteogenic differentiation of PDLSCs by inhibiting miR (show MLXIP Proteins)-21/Spry1 func...
Although the expression of SPRY1 was low when compared with other tumors, SPRY1 was variably expressed in primary Ewing sarcoma tumors and higher expression levels were significantly associated with improved outcome in a large patient cohort.
SPRY1 and SPRY2 (show SPRY2 Proteins) mRNA transcripts were significantly upregulated in human CRC (show CALR Proteins). Suppression of SPRY2 (show SPRY2 Proteins) repressed AKT2 (show AKT2 Proteins) and EMT (show ITK Proteins)-inducing transcription factors and significantly increased E-cadherin (show CDH1 Proteins) expression. Concurrent downregulation of SPRY1 and SPRY2 (show SPRY2 Proteins) also increased E-cadherin (show CDH1 Proteins) and suppressed mesenchymal markers in colon cancer cells.
Spry1 plays a selective role in at least a subset of triple-negative breast cancer to promote the malignant phenotype via enhancing EGF (show EGF Proteins)-mediated mesenchymal phenotype.
Suppression of SPRY1 by age-associated methylation inhibits the replenishment of the muscle stem cell pool.
Cosuppression of Sprouty and Sprouty-related negative regulators of FGF signalling in prostate cancer
There is an inverse correlation between the expression of Spry1 and growth, proliferation, invasion and migration of ovarian cancer cells.
Loss of Spry1/2 enhances the survival of effector CD8 (show CD8A Proteins)+ T cells and results in the formation of more protective memory cells. Deleting Spry1/2 in antigen-specific CD8 (show CD8A Proteins)+ T cells may have therapeutic potential for enhancing the survival and functionality of effector and memory CD8 (show CD8A Proteins)+ T cells in vivo.
The results show that lnc-Spry1 could act as an early mediator of TGF-beta (show TGFB1 Proteins) signaling and reveal different roles for a long noncoding RNA in modulating transcriptional and posttranscriptional gene expression.
modulation of stromal paracrine signaling and extracellular matrix remodeling by SPRY1 regulates mammary epithelial morphogenesis during postnatal development.
Here, we present a novel mouse model of pheochromocytoma consisting of double-heterozygous mice for Pten and Sprouty1 (Spry1), which leads to pheochromocytomas that appear at earlier onset and grow at a higher rate than those from Pten+/- mice.
Sprouty gain of function disrupts lens cellular processes and growth by restricting receptor tyrosine kinase (show ERBB3 Proteins) signaling.
In vivo analysis of thyroid glands from Spry1 knockout mice reveals that Spry1 induces a senescence-associated secretory phenotype via activation of the NFkappaB pathway.
showed that hSpry1 overexpression prevents VEGF (show VEGFA Proteins) secretion
Spry1 and Spry2 (show SPRY2 Proteins) coordination is required for normal development of the external genitalia in mice
May function as an antagonist of fibroblast growth factor (FGF) pathways and may negatively modulate respiratory organogenesis.
protein sprouty homolog 1
, sprouty, Drosophila, homolog of, 1 (antagonist of FGF signaling)
, sprouty 1 protein
, sprouty homolog 1, antagonist of FGF signaling (Drosophila)
, sprouty homolog 1, antagonist of FGF signaling
, sprouty 1
, sprouty homolog 1a, antagonist of FGF signaling
, sprouty homolog 1b, antagonist of FGF signaling
, inhibitor of receptor tyrosine kinases